\u65b0\u85e5\u5168\u7403\u5e02\u5834\u5e74\u589e\u4e0d\u6e1b\uff0c\u65b0\u85e5\u516c\u53f8\u70ba\u978f\u56fa\u71df\u6536\u7372\u5229\u3001\u5efa\u7acb\u7af6\u722d\u58c1\u58d8\uff0c\u7121\u4e0d\u7aed\u76e1\u6240\u80fd\u904b\u7528\u6cd5\u4ee4\u898f\u7bc4\u3001\u667a\u6167\u8ca1\u7522\u3001\u5546\u696d\u6a21\u5f0f\u7b49\u624b\u6bb5\uff0c\u963b\u6b62\u7af6\u722d\u8005\u9032\u5165\u5e02\u5834\uff0c\u78ba\u4fdd\u5408\u6cd5\u58df\u65b7\u65b0\u85e5\u5e02\u5834\u3002\u5176\u4e2d\u667a\u6167\u8ca1\u7522\u90e8\u5206\uff0c\u65b0\u85e5\u516c\u53f8\u900f\u904e\u5c08\u5229\u4f48\u5c40\u65bc\u5168\u7403\u653b\u57ce\u63a0\u5730\uff0c\u64da\u4ee5\u4fdd\u8b77\u5275\u65b0\u7814\u767c\u7522\u54c1\u7d44\u5408\u8207\u6280\u8853\u5e73\u53f0\uff0c\u4e26\u5c0d\u65bc\u4fb5\u5bb3\u8005\uff0c\u65b0\u85e5\u516c\u53f8\u7acb\u5373\u796d\u51fa\u8de8\u570b\u5c08\u5229\u4fb5\u6b0a\u8a34\u8a1f\uff0c\u963b\u6b62\u7af6\u722d\u8005\u74dc\u5206\u6bcf\u5e74\u9ad8\u9054\u6578\u5341\u5104\u7f8e\u5143\u7684\u5e02\u5834\u3002<\/p>\n
\u65b0\u85e5\u516c\u53f8\u63d0\u51fa\u8de8\u570b\u5c08\u5229\u4fb5\u6b0a\u8a34\u8a1f\uff0c\u7d93\u5e74\u6230\u706b\u983b\u4ecd\uff0c\u7159\u785d\u4e0d\u6b47\uff0c\u4f8b\u5982\uff0c2014\u5e741\u670823\u65e5\uff0cEli Lilly And Company\uff08Eli Lilly\uff09\u5728\u7f8e\u570b\u5370\u7b2c\u5b89\u90a3\u5dde\u5357\u5340\u5730\u65b9\u6cd5\u9662\u8a34\u544aGlenmark Generics\uff08Glenmark\uff09\uff0c\u4e3b\u5f35Glenmark\u5c0d\u65bcEli Lilly\u764c\u75c7\u7528\u85e5\u300cALIMTA\u300d\u63d0\u51faAbbreviated New Drug Application\uff08ANDA\uff09\u5b78\u540d\u85e5\u7533\u8acb\uff0c\u4fb5\u5bb3Eli Lilly\u4e4bU.S. Pat. 7,772,209\u3002\u540c\u4e00\u65e5\uff0cEli Lilly\u4ea6\u8a34\u544aPar Pharmaceutical Companies, Inc.\uff08Par\uff09\uff0c\u4e3b\u5f35Par\u91dd\u5c0dEli Lilly\u7684\u5fc3\u81df\u75c5\u7528\u85e5\u300cEFFIENT\u300d\u6240\u63d0\u51faANDA\u4fb5\u5bb3Eli Lilly\u4e4bU.S. Pat. 8,404,703\u548c8,569,325\u7b492\u4ef6\u5c08\u5229\u3002\u570b\u969b\u91ab\u85e5\u516c\u53f8\u63d0\u51fa\u5c08\u5229\u4fb5\u6b0a\u8a34\u8a1f\uff0c\u5747\u5c07\u5c08\u5229\u4f48\u5c40\u8207\u5c08\u5229\u8a34\u8a1f\u878d\u5165\u5e02\u5834\u8b00\u7565\u8a08\u5283\u5167\uff0c\u5c0d\u65bc\u570b\u969b\u91ab\u85e5\u516c\u53f8\u800c\u8a00\uff0c\u7d55\u975e\u55ae\u7d14\u6cd5\u5f8b\u6216\u667a\u6167\u8ca1\u7522\u696d\u52d9\uff0c\u800c\u662f\u54c1\u724c\u8a08\u756b\uff08Brand Plan\uff09\u8207\u696d\u52d9\u62d3\u5c55\uff08Business Development\uff09\u7684\u91cd\u8981\u74b0\u7bc0\u3002<\/p>\n
\u5728\u7f8e\u570b\u8207\u91ab\u85e5\u76f8\u95dc\u5df2\u516c\u958b\u5c08\u5229\uff0c\u65bc2002\u5e74\u9593\u5c31\u7d2f\u7a4d\u6578\u91cf\u7d0420\u842c\u4ef6\uff0c\u800c\u81f32012\u5e74\u9593\uff0c\u6578\u91cf\u6fc0\u589e\u523032.5\u842c\u4ef6\uff0c\u589e\u5e45\u81f3\u5c1160\uff05\u3002\u6b64\u5916\uff0c\u4f9d\u64da2013\u5e74\u5ea6\u7d71\u8a08\uff0c\u8207\u751f\u6280\u8207\u91ab\u85e5\u6709\u95dc\u7f8e\u570b\u5c08\u5229\u8a34\u8a1f\u6848\u4ef6\u91cf\uff0c\u5f9e1995\u5e74\u6392\u540d\u7b2c\u56db\uff0c\u5982\u4eca\u8e8d\u5347\u81f3\u7b2c\u4e8c\uff0c\u5224\u6c7a\u8ce0\u511f\u91d1\u6578\u984d\u4ea6\u6392\u540d\u7b2c\u4e8c\uff0c\u50c5\u6b21\u65bc\u8cc7\u901a\u8a0a\u7522\u696d\u3002\u56e0\u6b64\uff0c\u5168\u7403\u91ab\u85e5\u7af6\u722d\u8cfd\u5c40\u4e2d\uff0c\u5c08\u5229\u6210\u70ba\u5099\u6230\u5fc5\u9808\u8ecd\u706b\uff0c\u800c\u4e14\u667a\u6167\u8ca1\u7522\u8de8\u570b\u5708\u5730\u4f48\u5c40\uff0c\u5018\u82e5\u7a0d\u6709\u9583\u5931\uff0c\u4f01\u696d\u5546\u696d\u5229\u76ca\u53ef\u80fd\u5168\u76e4\u7686\u5931\u3002<\/p>\n
\u57fa\u65bc\u65b0\u85e5\u7814\u767c\u6642\u7a0b\u5197\u9577\uff0c\u81e8\u5e8a\u4e0d\u78ba\u5b9a\u6027\u9ad8\uff0c\u52a0\u4e0a\u5404\u570b\u5c08\u5229\u6cd5\u57fa\u65bc\u5065\u5eb7\u3001\u516c\u76ca\u8207\u502b\u7406\u7b49\u56e0\u7d20\u8003\u91cf\uff0c\u91dd\u5c0d\u7279\u5b9a\u91ab\u85e5\u7522\u696d\u767c\u660e\uff0c\u4e0d\u7d66\u4e88\u5c08\u5229\u4fdd\u8b77\uff0c\u81f4\u4f7f\u91ab\u85e5\u7522\u696d\u4e4b\u5275\u65b0\u7814\u767c\u6210\u679c\u8f49\u63db\u70ba\u5c08\u5229\u6642\uff0c\u8f49\u63db\u901f\u5ea6\u8f03\u6162\uff0c\u53ef\u5c08\u5229\u4e4b\u6a19\u7684\u53d7\u9650\uff0c\u5c08\u5229\u6578\u91cf\u76f8\u8f03\u5176\u4ed6\u7522\u696d\u81ea\u7136\u8f03\u5c11\u3002<\/p>\n
\u53e6\u5916\uff0c\u5c31\u91ab\u85e5\u7522\u54c1\u4e0a\u5e02\u5be9\u6838\u6cd5\u898f\u4f86\u770b\uff0c\u91ab\u85e5\u7522\u54c1\u6240\u53d7\u9650\u5236\u7a0b\u5ea6\u4e5f\u9ad8\u65bc\u5176\u5b83\u7522\u696d\uff0c\u4e14\u91ab\u85e5\u7522\u54c1\u4e0a\u5e02\u5be9\u6838\u6cd5\u898f\uff0c\u591a\u8207\u5404\u570b\u5c08\u5229\u6a5f\u5236\u9023\u7d50\uff0c\u4ee5\u65b0\u5316\u5b78\u5206\u5b50\u85e5\u7269\uff08New Chemical Entity, NCE\uff09\u70ba\u4f8b\uff0c\u5f9e\u7814\u7a76\u958b\u767cNCE\u5230NCE\u88ab\u6838\u6dee\u4e0a\u5e02\uff0c\u5e73\u5747\u8017\u6642\u5341\u5e74\u4ee5\u4e0a\uff0c\u53ef\u5c08\u5229\u4e4b\u6a19\u7684\uff0c\u9650\u65bc\u5316\u5b78\u5206\u5b50\u4e4b\u5404\u7a2e\u5316\u5b78\u7d50\u69cb \uff08\u5305\u542b\u7570\u69cb\u7269\u3001\u6676\u578b\u8207\u9e7d\u985e\uff09\u3001\u7528\u9014\uff08\u6307\u9069\u61c9\u75c7\uff09\u3001\u88fd\u9020\u8403\u53d6\u8207\u5408\u6210\u65b9\u6cd5\u3001\u91ab\u85e5\u7d44\u5408\u7269\u3001\u5291\u578b\u7b49\uff1b\u4f9d1984\u5e74\u7f8e\u570bHatch-Waxman\u6cd5\u6848\u898f\u5b9a\u5f97\u5217\u65bc\u6a58\u76ae\u66f8\uff08Orange Book\uff09\u4e4b\u5c08\u5229\u6a19\u7684\uff0c\u50c5\u5305\u542b\u539f\u6599\u85e5\uff08Drug Substance\uff09\u8207\u85e5\u7269\u5236\u5291\uff08Drug Product\uff09\u3002\u56e0\u6b64\uff0c\u91ab\u85e5\u7522\u696d\u7684\u667a\u6167\u8ca1\u7522\u4f48\u5c40\uff0c\u5176\u65b9\u5411\u3001\u6642\u6a5f\u3001\u65b9\u6cd5\u3001\u6548\u529b\u4ee5\u53ca\u6240\u61c9\u8003\u91cf\u9762\u5411\u8207\u6240\u6d89\u5c08\u696d\u77e5\u8b58\uff0c\u5373\u8207\u5176\u4ed6\u7522\u696d\u8fe5\u7570\u3002\u53f0\u7063\u65b0\u85e5\u516c\u53f8\u82e5\u6b20\u7f3a\u5c08\u696d\u65b9\u6cd5\u8207\u5de5\u5177\u8655\u7406\u5404\u985e\u667a\u6167\u8ca1\u7522\u696d\u52d9\uff0c\u5247\u52a3\u8cea\u8207\u52a3\u52e2\u300c\u667a\u8ca1\u4f48\u5c40\u300d\u53ef\u80fd\u5c0e\u81f4\u300c\u81ea\u88c1\u300d\u8207\u300c\u6016\u5c40\u300d\u3002<\/p>\n
\u65b0\u85e5\u7814\u767c\u6210\u679c\u7684\u5c08\u5229\u4f48\u5c40\uff0c\u662f\u8d77\u59cb\u65bc\u65b0\u85e5\u7814\u767c\uff08Drug Discovery\uff09\u968e\u6bb5\uff0c\u4e26\u61c9\u65bc\u7814\u767c\u904e\u7a0b\u4e0d\u65b7\u6aa2\u8a0e\u8207\u6301\u7e8c\u512a\u5316\u3002\u56e0\u6b64\uff0c\u65b0\u85e5\u516c\u53f8\u8655\u7406\u667a\u6167\u8ca1\u7522\u4f48\u5c40\uff0c\u5c1a\u9700\u5e02\u5834\u3001\u6280\u8853\u8207\u6cd5\u5f8b\u4e09\u5927\u8cc7\u8a0a\u8f14\u52a9\u3002\u8a73\u8a00\u4e4b\uff0c\u5e02\u5834\u8cc7\u8a0a\uff0c\u6db5\u84cb\u9700\u6c42\u9810\u4f30\u3001\u5e02\u5834\u9810\u4f30\u3001\u75be\u75c5\u8cc7\u8a0a\uff08\u5982\u75c5\u60a3\u8cc7\u8a0a\u3001\u60a3\u75c5\u6bd4\u7387\u3001\u5065\u4fdd\u5236\u5ea6\u7b49\uff09\u3001\u7522\u696d\u7d50\u69cb\u3001\u539f\u6599\u85e5\u4f9b\u61c9\u3001\u7af6\u722d\u5ee0\u5546\u7b49\uff1b\u6280\u8853\u8cc7\u8a0a\uff0c\u6db5\u84cb\u73fe\u5b58\u6280\u8853\u5206\u6790\u3001\u66ff\u4ee3\u6280\u8853\u5206\u6790\u3001\u6280\u8853\u767c\u5c55\u8108\u7d61\u3001\u7279\u5b9a\u6280\u8853\u9818\u57df\u4e3b\u8981\u7522\u5b78\u7814\u767c\u5c55\u3001\u71df\u904b\u81ea\u7531\u5206\u6790\uff08Freedom-to-Operate\uff09\u7b49\uff1b\u6cd5\u5f8b\u8cc7\u8a0a\uff0c\u6db5\u84cb\u5404\u570b\u4e0a\u5e02\u5be9\u6838\u6cd5\u898f\u3001\u5e02\u5834\u7368\u4f54\u512a\u60e0\u6a5f\u5236\u3001\u5c08\u5229\u6cd5\u4ee4\u898f\u7bc4\u53ca\u8a34\u8a1f\u3001\u6388\u6b0a\u3001\u6295\u8cc7\u3001\u4f75\u8cfc\u7b49\u52d5\u614b\u8cc7\u8a0a\u7b49\u3002<\/p>\n
\u64da\u6b64\uff0c\u65b0\u85e5\u516c\u53f8\u8de8\u570b\u667a\u6167\u8ca1\u7522\u4f48\u5c40\u8207\u7d93\u71df\uff0c\u9700\u6709\u719f\u6089\u5546\u696d\u6a21\u5f0f\u3001\u5275\u65b0\u93c8\u3001\u6295\u8cc7\u93c8\u3001\u7522\u696d\u93c8\u3001\u50f9\u503c\u93c8\u3001\u4f9b\u61c9\u93c8\u3001\u6388\u6b0a\u6280\u8f49\u3001\u5c08\u5229\u8a34\u8a1f\u3001\u5404\u570b\u91ab\u85e5\u6cd5\u4ee4\u898f\u7bc4\u7b49\u9805\u76ee\u4e4b\u5c08\u696d\u670d\u52d9\u7d44\u7e54\u5354\u540c\u63d0\u4f9b\u670d\u52d9\uff0c\u4e26\u9700\u5584\u7528\u5176\u5c08\u696d\u65b9\u6cd5\u3001\u5de5\u5177\u53ca\u7cfb\u7d71\u8655\u7406\u5404\u985e\u667a\u6167\u8ca1\u7522\u8abf\u67e5\u5206\u6790\u3001\u667a\u6167\u8ca1\u7522\u98a8\u96aa\u63a7\u7ba1\u3001\u667a\u6167\u8ca1\u7522\u4f48\u5c40\u7533\u8acb\u3001\u667a\u6167\u8ca1\u7522\u884c\u92b7\u7d93\u71df\u7b49\u696d\u52d9\uff0c\u65b0\u85e5\u516c\u53f8\u59cb\u6709\u6a5f\u6703\u5982\u540c\u524d\u8ff0\u570b\u969b\u85e5\u5ee0\u6a21\u5f0f\uff0c\u7acb\u99ac\u62ab\u888d\u4e0a\u9663\u4e14\u5feb\u901f\u8d0f\u5f97\u5e02\u5834\u3002<\/p>\n
\u5168\u6587\u7db2\u5740:http:\/\/www.chinatimes.com\/newspapers\/20140422000067-260202<\/p>\n
\u4ee5\u4e0a\u8a0a\u606f\u8f49\u81ea \u5de5\u5546\u6642\u5831 \u5f35\u6dd1\u8c9e\u4e16\u535a\u79d1\u6280\u9867\u554f\u516c\u53f8\u71df\u904b\u9577<\/p>\n","protected":false},"excerpt":{"rendered":"
\u65b0\u85e5\u5168\u7403\u5e02\u5834\u5e74\u589e\u4e0d\u6e1b\uff0c\u65b0\u85e5\u516c\u53f8\u70ba\u978f\u56fa\u71df\u6536\u7372\u5229\u3001\u5efa\u7acb\u7af6\u722d\u58c1\u58d8\uff0c\u7121\u4e0d\u7aed\u76e1\u6240\u80fd\u904b\u7528\u6cd5\u4ee4\u898f\u7bc4\u3001\u667a\u6167\u8ca1\u7522\u3001\u5546\u696d\u6a21\u5f0f\u7b49\u624b\u6bb5\uff0c\u963b\u6b62\u7af6\u722d\u8005\u9032\u5165\u5e02\u5834\uff0c\u78ba\u4fdd\u5408\u6cd5\u58df\u65b7\u65b0\u85e5\u5e02\u5834\u3002\u5176\u4e2d\u667a\u6167\u8ca1\u7522\u90e8\u5206\uff0c\u65b0\u85e5\u516c\u53f8\u900f\u904e\u5c08\u5229\u4f48\u5c40\u65bc\u5168\u7403\u653b […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-622","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/ipr.thu.edu.tw\/index.php?rest_route=\/wp\/v2\/posts\/622","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipr.thu.edu.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipr.thu.edu.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipr.thu.edu.tw\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ipr.thu.edu.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=622"}],"version-history":[{"count":1,"href":"https:\/\/ipr.thu.edu.tw\/index.php?rest_route=\/wp\/v2\/posts\/622\/revisions"}],"predecessor-version":[{"id":623,"href":"https:\/\/ipr.thu.edu.tw\/index.php?rest_route=\/wp\/v2\/posts\/622\/revisions\/623"}],"wp:attachment":[{"href":"https:\/\/ipr.thu.edu.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=622"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipr.thu.edu.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=622"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipr.thu.edu.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=622"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}